Metabolic and haemodynamic effects of increased circulating adrenaline in man: effect of labetalol, an alpha and beta blocker

A. D. Struthers, R. Whitesmith, J. L. Reid

    Research output: Contribution to journalArticlepeer-review

    20 Citations (Scopus)

    Abstract

    To simulate increased sympathoadrenal activity adrenaline was infused in normotensive subjects to achieve plasma adrenaline concentrations similar to those seen after myocardial infarction or hypoglycaemia. Adrenaline was infused after pretreatment for five days with labetalol 200 mg twice daily or placebo given in a random order. The rise in systolic blood pressure and the fall in diastolic blood pressure observed after the infusion of adrenaline (0.06 micrograms/kg/min) were prevented by labetalol and no increase in blood pressure was seen. Adrenaline infusion after pretreatment with placebo caused a profound fall in the serum potassium concentration (4.12-3.20 mmol(mEq)/l). Pretreatment with labetalol completely blocked adrenaline induced hypokalaemia (3.92-3.95 mmol(mEq)/l). Adrenaline induced T wave flattening and QTc prolongation were also prevented by labetalol. Thus labetalol can prevent the electrocardiographic, haemodynamic, and hypokalaemic effects of increased circulating adrenaline in man. The combination of alpha and beta blockade appears to be required to block the haemodynamic effects of adrenaline, and labetalol may, therefore, be useful in controlling both the metabolic and circulatory responses during increased sympathoadrenal activity.
    Original languageEnglish
    Pages (from-to)277-281
    Number of pages5
    JournalBritish Heart Journal
    Volume50
    Issue number3
    DOIs
    Publication statusPublished - Sep 1983

    Fingerprint Dive into the research topics of 'Metabolic and haemodynamic effects of increased circulating adrenaline in man: effect of labetalol, an alpha and beta blocker'. Together they form a unique fingerprint.

    Cite this